CAREDX, INC. Proceeds from (Repayments of) Restricted Cash, Financing Activities
CAREDX, INC. (CDNA) reported Proceeds from (Repayments of) Restricted Cash, Financing Activities of -$9.38 million for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-22.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromRepaymentsOfRestrictedCashFinancingActivities · last filed 2018-03-22
- CAREDX, INC. proceeds from (repayments of) restricted cash, financing activities for the quarter ending 2017-12-31 was $0.00.
- CAREDX, INC. proceeds from (repayments of) restricted cash, financing activities for the quarter ending 2017-09-30 was $0.00.
- CAREDX, INC. proceeds from (repayments of) restricted cash, financing activities for the quarter ending 2017-06-30 was $0.00.
- CAREDX, INC. proceeds from (repayments of) restricted cash, financing activities for the quarter ending 2017-03-31 was -$9.38M.
- CAREDX, INC. proceeds from (repayments of) restricted cash, financing activities for fiscal 2017 was -$9.38M.
- CAREDX, INC. proceeds from (repayments of) restricted cash, financing activities for fiscal 2016 was $0.00.
- CAREDX, INC. proceeds from (repayments of) restricted cash, financing activities for fiscal 2015 was $0.00.
| Period end | Proceeds from (Repayments of) Restricted Cash, Financing Activities 3 month | Proceeds from (Repayments of) Restricted Cash, Financing Activities 6 month | Proceeds from (Repayments of) Restricted Cash, Financing Activities 9 month | Proceeds from (Repayments of) Restricted Cash, Financing Activities 12 month |
|---|---|---|---|---|
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-22 | $0.00 derived: sum of 2 quarters · filed 2018-03-22 | $0.00 derived: sum of 3 quarters · filed 2018-03-22 | -$9.38M 10-K · filed 2018-03-22 |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $0.00 derived: sum of 2 quarters · filed 2017-11-09 | -$9.38M 10-Q · filed 2017-11-09 | -$9.38M derived: sum of 4 quarters · filed 2018-03-22 |
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-11 | -$9.38M 10-Q · filed 2017-08-11 | -$9.38M derived: sum of 3 quarters · filed 2018-03-22 | -$9.38M derived: sum of 4 quarters · filed 2018-03-22 |
| 2017-03-31 | -$9.38M 10-Q · filed 2017-06-09 | -$9.38M derived: sum of 2 quarters · filed 2018-03-22 | -$9.38M derived: sum of 3 quarters · filed 2018-03-22 | -$9.38M derived: sum of 4 quarters · filed 2018-03-22 |
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-22 | $0.00 derived: sum of 2 quarters · filed 2018-03-22 | $0.00 derived: sum of 3 quarters · filed 2018-03-22 | $0.00 10-K · filed 2018-03-22 |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $0.00 derived: sum of 2 quarters · filed 2017-11-09 | $0.00 10-Q · filed 2017-11-09 | |
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-11 | $0.00 10-Q · filed 2017-08-11 | ||
| 2016-03-31 | $0.00 10-Q · filed 2017-06-09 | |||
| 2015-12-31 | $0.00 10-K · filed 2018-03-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| BIODESIX INC (BDSX) | United States | $0.312B |